Apimeds Pharmaceuticals Us, Stock Cash Flow From Operations
| APUS Stock | 2.05 0.03 1.44% |
Fundamental analysis of Apimeds Pharmaceuticals allows traders to better anticipate movements in Apimeds Pharmaceuticals' stock price by examining its financial health and performance throughout various phases of its business cycle.
Apimeds | Cash Flow From Operations | Build AI portfolio with Apimeds Stock |
Apimeds Pharmaceuticals US, Company Cash Flow From Operations Analysis
Apimeds Pharmaceuticals' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Apimeds Pharmaceuticals Cash Flow From Operations | (733.53 K) |
Most of Apimeds Pharmaceuticals' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apimeds Pharmaceuticals US, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Apimeds Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Apimeds Pharmaceuticals is extremely important. It helps to project a fair market value of Apimeds Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Apimeds Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apimeds Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apimeds Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Apimeds Pharmaceuticals US, has (733,526) in Cash Flow From Operations. This is 100.14% lower than that of the Capital Markets sector and 100.2% lower than that of the Financials industry. The cash flow from operations for all United States stocks is 100.08% higher than that of the company.
Apimeds Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apimeds Pharmaceuticals' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apimeds Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apimeds Pharmaceuticals by comparing valuation metrics of similar companies.Apimeds Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers.
Apimeds Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Apimeds Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Apimeds Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Apimeds Fundamentals
| Return On Asset | -4.09 | ||||
| Current Valuation | 21.11 M | ||||
| Shares Outstanding | 11.58 M | ||||
| Shares Owned By Insiders | 81.96 % | ||||
| Number Of Shares Shorted | 3.22 K | ||||
| EBITDA | (1.27 M) | ||||
| Net Income | (1.39 M) | ||||
| Total Debt | 596.84 K | ||||
| Book Value Per Share | (0.22) X | ||||
| Cash Flow From Operations | (733.53 K) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Market Capitalization | 24.31 M | ||||
| Total Asset | 13.06 K | ||||
| Retained Earnings | (4.39 M) | ||||
| Working Capital | (1.01 M) | ||||
| Net Asset | 13.06 K |
About Apimeds Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apimeds Pharmaceuticals US,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apimeds Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apimeds Pharmaceuticals US, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.